Clinical trial
Correlation Between SV2A Expression in Tumour Tissue and Efficacy of…
NCT00454935 · Amsterdam UMC, location VUmc, Other · Unknown status
Key facts
| NCT number | NCT00454935 |
|---|---|
| Title | Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy |
| Official title | Correlation Between SV2A Expression in Tumour Tissue and Efficacy of Levetiracetam in Glioma Patients With Epilepsy |
| Lead sponsor | Amsterdam UMC, location VUmc, Other |
| Collaborators | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Medical Center Haaglanden |
| Status | Unknown status |
| Study type | Observational |
| Conditions | Epilepsy, Glioma |
| Enrollment | 40 |
| Start date | Apr 1, 2007 |
| Completion | Oct 1, 2008 |
| First posted | Apr 2, 2007 |
| Last update posted | Jun 9, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: